Title |
Prevention of mother-to-child HIV transmission in resource-limited settings: assessment of 99 Viramune Donation Programmes in 34 countries, 2000–2011
|
---|---|
Published in |
BMC Public Health, May 2013
|
DOI | 10.1186/1471-2458-13-470 |
Pubmed ID | |
Authors |
Joël Ladner, Marie-Hélène Besson, Mariana Rodrigues, Kelley Sams, Etienne Audureau, Joseph Saba |
Abstract |
Transmission of HIV from mother-to-child during pregnancy, labor, or breastfeeding is the primary cause of pediatric HIV infection in sub-Saharan Africa. A regimen of single-dose nevirapine administered to both HIV-positive pregnant women and their infants has been shown to lower the risk of mother-to-child transmission (MTCT) of HIV. In an effort to facilitate scale-up of PMTCT programs in low-income countries, Boehringer Ingelheim, the manufacturer of Viramune (branded nevirapine), initiated the Viramune Donation Programme (VDP) in 2000. The aim of this study was to evaluate the impact of the VDP on participating institutions. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 18% |
Unknown | 9 | 82% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 9 | 82% |
Practitioners (doctors, other healthcare professionals) | 2 | 18% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | <1% |
United States | 1 | <1% |
Unknown | 177 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 28 | 16% |
Student > Master | 28 | 16% |
Student > Ph. D. Student | 18 | 10% |
Student > Bachelor | 16 | 9% |
Student > Doctoral Student | 14 | 8% |
Other | 31 | 17% |
Unknown | 44 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 39 | 22% |
Social Sciences | 26 | 15% |
Nursing and Health Professions | 20 | 11% |
Psychology | 11 | 6% |
Business, Management and Accounting | 6 | 3% |
Other | 29 | 16% |
Unknown | 48 | 27% |